Rani Therapeutics Holdings, Inc.
RANI
$0.84
-$0.03-3.73%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.09% | 31.75% | -90.41% | 19.13% | 7.87% |
| Total Depreciation and Amortization | -5.59% | -13.44% | -16.59% | -7.08% | -4.38% |
| Total Amortization of Deferred Charges | -- | -- | -43.10% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 20.15% | -69.70% | 1,243.29% | 153.07% | 49.43% |
| Change in Net Operating Assets | -253.23% | -116.07% | 2,397.69% | -121.38% | 4,242.86% |
| Cash from Operations | -38.93% | -2,309.86% | 105.81% | 12.65% | 28.87% |
| Capital Expenditure | -113.33% | -- | -- | 100.00% | 27.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -496.47% | 92.14% | -- | -100.00% | -68.54% |
| Cash from Investing | -494.12% | 92.09% | -- | -100.00% | -68.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -152.59% | 0.00% | 0.00% |
| Issuance of Common Stock | 376,200.00% | -100.00% | 3,746.37% | -25.57% | 9,295.24% |
| Repurchase of Common Stock | 71.88% | -52.38% | -200.00% | 12.50% | 65.22% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -2,163.49% | -- | -- |
| Cash from Financing | 69,751.85% | -100.06% | 4,545.19% | -636.70% | 105.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 46.78% | -163.31% | 333.43% | -5,882.86% | -98.35% |